Total Payments
$7,389
2024 Payments
$1,638
Companies
42
Transactions
397
Medicare Patients
1,404
Medicare Billing
$114,100
Payment Breakdown by Category
Food & Beverage$7,383 (99.9%)
Education$5.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,383 | 396 | 99.9% |
| Education | $5.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,801 | 93 | $0 (2024) |
| Lilly USA, LLC | $703.54 | 36 | $0 (2024) |
| PFIZER INC. | $556.75 | 33 | $0 (2024) |
| ABBVIE INC. | $519.86 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $495.52 | 28 | $0 (2024) |
| Amgen Inc. | $441.47 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $380.54 | 16 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $368.15 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $262.02 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $256.14 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,638 | 80 | Novo Nordisk Inc ($356.04) |
| 2023 | $1,445 | 74 | Novo Nordisk Inc ($316.05) |
| 2022 | $1,122 | 55 | Novo Nordisk Inc ($336.55) |
| 2021 | $684.31 | 38 | Novo Nordisk Inc ($164.58) |
| 2020 | $425.86 | 23 | Novo Nordisk Inc ($92.47) |
| 2019 | $872.29 | 50 | Novo Nordisk Inc ($250.70) |
| 2018 | $654.44 | 41 | Novo Nordisk Inc ($164.59) |
| 2017 | $547.40 | 36 | Novo Nordisk Inc ($119.90) |
All Payment Transactions
397 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | bioMerieux Inc | BIOFIRE SPOTFIRE Respiratory (R) Panel (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Diagnostics | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.59 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $2.03 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: VACCINE | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $3.85 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $7.06 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.48 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Biological | ||||||
| 09/04/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Hematology | ||||||
| 08/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEPHROLOGY | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 276 | 476 | $74,963 | $24,756 |
| 2022 | 11 | 357 | 647 | $71,968 | $30,743 |
| 2021 | 11 | 348 | 586 | $60,302 | $24,721 |
| 2020 | 12 | 423 | 694 | $84,468 | $33,879 |
Total Patients
1,404
Total Services
2,403
Medicare Billing
$114,100
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 130 | $39,784 | $11,657 | 29.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $7,541 | $3,668 | 48.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 22 | $8,836 | $2,551 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $5,181 | $2,173 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 28 | $5,966 | $1,640 | 27.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 28 | $1,990 | $910.00 | 45.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 74 | $1,830 | $704.48 | 38.5% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 15 | 15 | $1,215 | $502.35 | 41.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $877.00 | $422.50 | 48.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 40 | 120 | $1,440 | $385.20 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 17 | $303.00 | $142.80 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 163 | $36,639 | $15,408 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 32 | 32 | $8,800 | $4,465 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 59 | $9,582 | $3,454 | 36.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 14 | $5,830 | $2,494 | 42.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 19 | 19 | $1,710 | $1,335 | 78.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,925 | $1,119 | 58.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 44 | 93 | $2,418 | $892.91 | 36.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 50 | 166 | $2,822 | $538.11 | 19.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 16 | 16 | $1,040 | $479.52 | 46.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 14 | $770.00 | $451.12 | 58.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 36 | $432.00 | $107.13 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 153 | $34,034 | $14,024 | 41.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 67 | $10,496 | $4,449 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $3,850 | $2,001 | 52.0% |
About Dr. Charlecinth Roberts, MD
Dr. Charlecinth Roberts, MD is a Family Medicine healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1700105624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charlecinth Roberts, MD has received a total of $7,389 in payments from pharmaceutical and medical device companies, with $1,638 received in 2024. These payments were reported across 397 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,383).
As a Medicare-enrolled provider, Roberts has provided services to 1,404 Medicare beneficiaries, totaling 2,403 services with total Medicare billing of $114,100. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hartford, CT
- Active Since 05/18/2010
- Last Updated 03/05/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700105624
Products in Payments
- Ozempic (Drug) $616.48
- MOUNJARO (Drug) $463.97
- Rybelsus (Drug) $407.11
- XIFAXAN (Drug) $399.02
- UBRELVY (Drug) $244.55
- VRAYLAR (Drug) $213.37
- TRULICITY (Drug) $213.21
- BREZTRI (Drug) $208.91
- Tresiba (Drug) $193.54
- Veozah (Drug) $179.24
- REXULTI (Drug) $177.07
- TRELEGY ELLIPTA (Drug) $174.72
- SHINGRIX (Biological) $168.03
- Prolia (Biological) $167.51
- JANUVIA (Drug) $163.57
- ELIQUIS (Drug) $162.92
- CHANTIX (Drug) $161.27
- Victoza (Drug) $153.19
- SOLIQUA 100/33 (Biological) $128.58
- AIRSUPRA (Drug) $124.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hartford
Mohammad Samer Younes, M.d, M.D
Family Medicine — Payments: $16,845
Family Medicine $16,845
Mark Belsky, Md, MD
Family Medicine — Payments: $7,778
Family Medicine $7,778
Dr. Nieves Hornbeck, M.d, M.D
Family Medicine — Payments: $7,619
Family Medicine $7,619
Susan Wiskowski, Md, MD
Family Medicine — Payments: $4,449
Family Medicine $4,449
Sama Alvi, M.d, M.D
Family Medicine — Payments: $4,362
Family Medicine $4,362
Ms. Magilta Joseph, Msm Aprn Fnp-Bc, MSM APRN FNP-BC
Family Medicine — Payments: $2,876
Family Medicine $2,876